Kairos Pharma Ltd. (KAPA)
0.537
-0.01
(-1.47%)
USD |
NYAM |
May 26, 12:42
Kairos Pharma EPS Diluted (Quarterly) : -0.0787 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.654M |
| Total Expenses (Quarterly) | 1.654M |
| Enterprise Value | 7.994M |
| Earnings Yield | -55.14% |
| Normalized Earnings Yield | -53.30 |